Roger E. Moe

3.0k total citations
39 papers, 2.4k citations indexed

About

Roger E. Moe is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Roger E. Moe has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 18 papers in Pathology and Forensic Medicine and 18 papers in Oncology. Recurrent topics in Roger E. Moe's work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (17 papers) and Breast Implant and Reconstruction (8 papers). Roger E. Moe is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (17 papers) and Breast Implant and Reconstruction (8 papers). Roger E. Moe collaborates with scholars based in United States and South Africa. Roger E. Moe's co-authors include Benjamin O. Anderson, Christopher I. Li, Janet R. Daling, David R. Byrd, Raymond S. Yeung, David A. Mankoff, Mary Austin-Seymour, Robert B. Livingston, Cam Solomon and David B. Thomas and has published in prestigious journals such as JAMA, Cancer and Annals of Surgery.

In The Last Decade

Roger E. Moe

39 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger E. Moe United States 23 1.4k 1.1k 1.0k 611 292 39 2.4k
S J Schnitt United States 17 1.6k 1.1× 816 0.8× 1.1k 1.1× 445 0.7× 203 0.7× 33 2.1k
Mirella Merson Italy 14 1.7k 1.2× 1.0k 1.0× 1.0k 1.0× 700 1.1× 192 0.7× 26 2.3k
Alison Estabrook United States 22 1.3k 0.9× 574 0.5× 905 0.9× 823 1.3× 244 0.8× 46 2.1k
F. Campana France 22 1.2k 0.8× 840 0.8× 732 0.7× 350 0.6× 320 1.1× 68 2.0k
J.A. van Dongen Netherlands 18 2.0k 1.4× 1.1k 1.0× 1.2k 1.2× 847 1.4× 280 1.0× 36 2.6k
Marcella Del Vecchio Italy 14 2.3k 1.6× 1.2k 1.1× 1.3k 1.2× 1.1k 1.8× 275 0.9× 18 3.1k
Lorie L. Hughes United States 15 1.5k 1.1× 1.1k 1.0× 804 0.8× 493 0.8× 214 0.7× 22 2.2k
Parvis Gamagami Switzerland 19 2.3k 1.6× 875 0.8× 1.9k 1.9× 917 1.5× 233 0.8× 31 2.7k
M.A. Chaudary United Kingdom 23 1.0k 0.7× 671 0.6× 626 0.6× 347 0.6× 109 0.4× 48 1.6k
Anne de la Rochefordière France 26 1.6k 1.1× 1.1k 1.1× 832 0.8× 591 1.0× 141 0.5× 79 2.7k

Countries citing papers authored by Roger E. Moe

Since Specialization
Citations

This map shows the geographic impact of Roger E. Moe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger E. Moe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger E. Moe more than expected).

Fields of papers citing papers by Roger E. Moe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger E. Moe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger E. Moe. The network helps show where Roger E. Moe may publish in the future.

Co-authorship network of co-authors of Roger E. Moe

This figure shows the co-authorship network connecting the top 25 collaborators of Roger E. Moe. A scholar is included among the top collaborators of Roger E. Moe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger E. Moe. Roger E. Moe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moe, Roger E. & Benjamin O. Anderson. (2005). Distinctive biology of pleomorphic lobular carcinoma of the breast. Journal of Surgical Oncology. 90(2). 47–50. 9 indexed citations
2.
Reed, Daniel, Skyler K. Lindsley, Gary N. Mann, et al.. (2005). Axillary lymph node dose with tangential breast irradiation. International Journal of Radiation Oncology*Biology*Physics. 61(2). 358–364. 65 indexed citations
3.
Baldwin, Laura‐Mae, Stephen H. Taplin, Harvey Friedman, & Roger E. Moe. (2004). Access to multidisciplinary cancer care. Cancer. 100(4). 701–709. 59 indexed citations
4.
Paik, Jisun, et al.. (2003). Retinoids, Retinoic Acid Receptors, and Breast Cancer. Cancer Investigation. 21(2). 304–312. 11 indexed citations
5.
Li, Christopher I., Roger E. Moe, & Janet R. Daling. (2003). Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years. Archives of Internal Medicine. 163(18). 2149–2149. 79 indexed citations
6.
Moskovitz, Alexander H., Benjamin O. Anderson, Raymond S. Yeung, et al.. (2001). Axillary web syndrome after axillary dissection. The American Journal of Surgery. 181(5). 434–439. 144 indexed citations
7.
Byrd, David R., Lisa K. Dunnwald, David A. Mankoff, et al.. (2001). Internal Mammary Lymph Node Drainage Patterns in Patients With Breast Cancer Documented by Breast Lymphoscintigraphy. Annals of Surgical Oncology. 8(3). 234–240. 92 indexed citations
8.
Li, Christopher I., Benjamin O. Anderson, Peggy L. Porter, et al.. (2000). Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 88(11). 2561–2569. 124 indexed citations
9.
Hathaway, Peter, David A. Mankoff, Kenneth R. Maravilla, et al.. (1999). Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary Experience. Radiology. 210(3). 807–814. 87 indexed citations
10.
11.
12.
Moe, Roger E., et al.. (1994). Growth factor profiles in breast cyst fluid identify women with increased breast cancer risk. The American Journal of Surgery. 167(5). 523–530. 5 indexed citations
13.
Buchholz, Thomas A., Mary Austin-Seymour, Roger E. Moe, et al.. (1993). Effect of delay in radiation in the combined modality treatment of breast cancer. International Journal of Radiation Oncology*Biology*Physics. 26(1). 23–35. 170 indexed citations
14.
Moe, Roger E., et al.. (1993). Identification of multiple proliferative growth factors in breast cyst fluid. The American Journal of Surgery. 166(3). 237–243. 24 indexed citations
15.
Porter, Peggy L., et al.. (1991). C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia. Cancer. 68(2). 331–334. 67 indexed citations
16.
Moe, Roger E., Kris S. Moe, Peggy L. Porter, et al.. (1991). Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers. The American Journal of Surgery. 161(5). 580–583. 7 indexed citations
17.
Tapper, David, et al.. (1990). Identification of a unique biological tumor marker in human breast cyst fluid and breast cancer tissue. The American Journal of Surgery. 159(5). 473–478. 9 indexed citations
18.
Diehr, Paula, et al.. (1989). Treatment Modality and Quality Differences for Black and White Breast-Cancer Patients Treated in Community Hospitals. Medical Care. 27(10). 942–958. 83 indexed citations
19.
Berg, Alfred O., et al.. (1983). An evaluation of individual components of breast self-examination.. PubMed. 17(5). 921–2. 1 indexed citations
20.
Namkung, Pearl C., Roger E. Moe, & Philip H. Pétra. (1979). Stability of estrogen receptors in frozen human breast tumor tissue.. PubMed. 39(3). 1124–5. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026